Jan 012025
 
Drug Name
Active Ingredient(s)
Approval Date
FDA-Approved Use on Approval Date
Press Release
Drug Trials Snapshot
Alhemo concizumab-mtci 12/20/2024 For routine prophylaxis to prevent bleeding episodes in hemophilia A and B
Alyftrek  vanzacaftor, tezacaftor, and deutivacaftor 12/20/2024 To treat cystic fibrosis
Tryngolza olezarsen 12/19/2024 To treat familial chylomicronemia syndrome
Ensacove ensartinib 12/18/2024 To treat non-small cell lung cancer
Crenessity crinecerfont 12/13/2024 To treat classic congenital adrenal hyperplasia Press Release
Unloxcyt cosibelimab-ipdl 12/13/2024 To treat cutaneous squamous cell carcinoma
Bizengri zenocutuzumab-zbco 12/4/2024 To treat non-small cell lung cancer and pancreatic adenocarcinoma

Sorry, the comment form is closed at this time.